An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation

An aerosol formulation containing 7.5 mg of R-salbutamol sulfate was developed. The aerosol was nebulized with an air-jet nebulizer, and further assessed according to the new European Medicines Agency (EMA) guidelines. A breath simulator was used for studies of delivery rate and total amount of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuemei, Liu, Qing, Hu, Junhua, Xu, Ling, Tan, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590724/
https://www.ncbi.nlm.nih.gov/pubmed/26579368
http://dx.doi.org/10.1016/j.apsb.2013.12.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590724/
https://www.ncbi.nlm.nih.gov/pubmed/26579368
http://dx.doi.org/10.1016/j.apsb.2013.12.010

Ejemplares similares